Consolidated Condensed Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Cash flows from operating activities:
Net income	$ 124,400	$ 221,800
Depreciation and amortization	180,500	175,400
Settlement of contingent consideration	0	(40,700)
Change in fair value of contingent consideration	(31,800)	0
Accrual for acquisition termination fee	45,000	0
Net changes in operating capital	(103,000)	(52,400)
Other non-cash items	75,700	(6,300)
Net cash provided by operating activities	290,800	297,800
Cash flows from investing activities:
Purchases of property, plant and equipment	(156,600)	(100,500)
Acquisitions of businesses and assets, net of cash acquired, and other	(38,700)	(1,637,100)
Proceeds from sale of interest in a subsidiary	0	52,600
Net cash used in investing activities	(195,300)	(1,685,000)
Cash flows from financing activities:
Proceeds from long-term debt, net of issuance costs	1,199,300	1,499,500
Repayments of long-term debt	(985,500)	(549,000)
Net (repayments of) proceeds from short-term debt	(342,500)	832,300
Net proceeds (payments) related to share-based compensation awards	2,100	(7,500)
Dividends on common stock	(1,500)	(1,500)
Repurchase of common stock	0	(78,500)
Issuance of common stock for employee stock purchase plan	3,700	3,400
Settlement of contingent consideration	0	(2,200)
Net cash (used in) provided by financing activities	(124,400)	1,696,500
Effect of exchange rate changes on cash, cash equivalents and restricted cash	2,400	(6,300)
Net (decrease) increase in cash, cash equivalents, and restricted cash	(26,500)	303,000
Cash, cash equivalents, and restricted cash at beginning of period	138,600	96,600
Cash, cash equivalents, and restricted cash at end of period	112,100	399,600
Reconciliation of cash flow information:
Cash and cash equivalents	111,900	399,200
Restricted cash included in other current assets	200	400
Total cash, cash equivalents, and restricted cash	$ 112,100	$ 399,600